Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents
Evaluate the efficacy and safety of subcutaneous ketamine added to usual treatment in the management of depressive episodes with suicidal ideation or behavior in adolescent patients, compared to usual treatment added to placebo (midazolam).
- Status
- planned
- Phase
- Phase 3
- Institution
- Federal University of São Paulo
- Start date
- 2025-05-01
- End date
- 2028-04-01
- Registry ID
- NCT06957704
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.